In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Teladoc (TDOC – Research Report), with a price target of $14.00. The company’s shares closed ...

In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on Teladoc (TDOC – Research Report), with a price target of $9.00. The company’s shares closed yesterday at $9.51.

In the latest trading session, Teladoc (TDOC) closed at $8.60, marking a -0.92% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.22%. At the same time ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (Symbol: TDOC), where a total of 24,136 contracts have traded so far ...

Hello, and welcome to the Teladoc Health third quarter 2024 call. My name is Alex, and I will be coordinating the call today. [Operator instructions] I'll now hand over to your host, Michael ...

In this article, we are going to take a look at where Teladoc Health Inc. (NYSE:TDOC) stands against the other US stocks. As the market continues progressing, there is a cautiously optimistic ...

Teladoc Health shares are moving higher in extended trading Wednesday after the company reported financial results for the third quarter that topped analyst expectations. Adam Eckert Future ...

Teladoc Health Inc. (NYSE:TDOC) is a telemedicine and virtual healthcare company headquartered in the US that provides services like telehealth, medical opinions, AI and analytics, telehealth ...

Teladoc Health, Inc. shows signs of bottoming out after withdrawing guidance due to customer acquisition issues, particularly in the BetterHelp division. The new CEO must drive product innovation ...

In a page one article in The Tennessean of Oct. 11 TDOC Commissioner Frank Strada says his 36 years of experience requires no need for oversight. Sen. Mark Pody, R- Lebanon, has diplomatically ...